Genmab chooses Ibex to take gene candidates to IND in 12 months

New contract extends the partnership between the Danish biotech company and Lonza

picture of

Breaking News

Westleaf gains standard processing licence from Health Canada

Cannabis extraction company can now create and sell derivative products through commercial arrangements

Avid Bioservices quadruples process development footprint

Specific enhancements to the new suites include the addition of 24 advanced benchtop process development bioreactors, ...

Mile High Labs Broomfield facility enters operation

The CBD manufacturer revives former Novartis/Sandoz pharma plant with capacity for capsules, tablets, topicals, and ...

Outsourcing in-house processes and releasing capacity

Mark Riemer, Commercial Manager at SternMaid describes the benefits of outsourcing and the services that a good ...

TRU Cleanroom Cleaning company launches in Belgium

The new company covers preparation of the cleaning & disinfection programme and implementation and monitoring of it ...

Sekisui invests $1.9m in new bioprocess innovation centre in the UK

Headquartered in Burlington, MA, US, Sekisui is planning future investment in expanding cGMP manufacturing capabilities

Case Study: Phase I to commercial in 18 months

Gabor Heltovics, Druggability Technologies CEO, talks about using Quotient Sciences to progress and scale-up an ...

Pepscan doubles GMP peptide production capacity

The Holland-based peptide CDMO has also strengthened QMS and process documentation

Contract win sees Lonza develop and manufacture gene therapies for Prevail

New York-based Prevail Therapeutics has chosen the Swiss CDMO for GMP manufacturing of the AAV9-based gene therapy for ...

Process optimisation with flow chemistry

WuXi STA, the Chinese CDMO with a global footprint, embraces the need to develop drugs for customers using safer, more ...

Stainless steel products in contemporary bioprocessing

ASEPCO's Mark Embury on the shift from stainless steel to single-use systems in the pharmaceutical manufacturing sector

Small molecule CDMOs reacting to changing market demands

The pharmaceutical industry continues to evolve in two interesting ways: first, the development pipeline sees a variety ...

Novasep opens viral vector fill-finish facility

The Senefill facility in Belgium is part of Novasep's flagship centre for the manufacturing of commercial viral vectors

Rentschler Biopharma reveals push for expanding operation in Japan

The German CDMO has secured contracts with Japanese pharmaceuticals through collaboration with Summit Pharmaceuticals ...